High incidence of intrahepatic cholangiocarcinoma in end-stage renal disease patients in Taiwan: analysis of a nationwide database with molecular insight of aristolochic acid exposure | Synapse
March 3, 2026
High incidence of intrahepatic cholangiocarcinoma in end-stage renal disease patients in Taiwan: analysis of a nationwide database with molecular insight of aristolochic acid exposure
Key Points
Intrahepatic cholangiocarcinoma occurs more frequently in end-stage renal disease patients in Taiwan.
The analysis indicates that exposure to aristolochic acid may contribute to this increased risk.
Nationwide database investigation helps inform the molecular insights related to this cancer.
Findings highlight a potential environmental risk factor for cholangiocarcinoma among renal patients.